Surbhi Sidana

I am a hematologist/oncologist specializing in the treatment of multiple myeloma and related disorders. I am an Associate Professor in the Division of BMT/ Cell Therapy Division at Stanford University. I lead the Myeloma Disease Focused Group and am the Associate Director for Clinical Research for the Division. I have a broad research portfolio that includes clinical trials of novel therapies in myeloma, translational and outcomes research. I have a special focus on immunotherapy related research and am the principal investigator of several clinical trials of CAR-T cell therapy and bispecific antibodies in myeloma. I also co-lead a multi-center consortium of academic medical centers in the US collaborating to generate insights from real-world application of CAR-T therapy and bispecific antibodies in myeloma. I am actively involved with cooperative groups and professional societies, including holding leadership positions with the goal of advancing treatment of hematological disorders.